Delivery Order SPE2DB22D2005-SPE2DB25FJMZ6
Award Date 5/30/25
Potential Completion Date 6/23/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA, leveraging the company's extensive capabilities as a major pharmaceutical distributor to the federal healthcare system. The delivery location is...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract. The award was made on October 31, 2025, with an ultimate completion date of November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $26,519.00 to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 MG tablets (60-count units). This firm fixed-price delivery order, issued on July 14, 2025, with completion targeted for August 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $26,519.00 for SCEMBLIX 40 mg tablets (60-count units) on August 12, 2025, with completion scheduled for September 3, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) under a competitively awarded, non-set-aside contract. The delivery order, issued on September 22, 2025, carries an ultimate completion date of October 14, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling...
- On January 23, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $15,956.33 to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 mg tablets (60-count units). This firm fixed-price, non-set-aside contract will be performed at the company's Conshohocken, Pennsylvania location, with an ultimate completion date of February 13, 2026. The delivery order is a child contract under AmerisourceBergen's parent company Cencora, Inc., which holds a substantial Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,973.47 for SCEMBLIX 40 mg tablets (60-count units) on December 30, 2025, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $27,946.94 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on November 18, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $13,973.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a non-set-aside competitive award with an ultimate completion date of January 14, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...